RSV Vaccination to Reduce Recurrent AECOPD
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Clinical Trials Related to RSV
Related studies linked through entity extraction aliases.
A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age Infected With Respiratory Syncytial Virus
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study to Evaluate the Safety of a Lyophilized RSV mRNA Vaccine
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
RSV Burden in Hong Kong
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Covid Flu A/B and RSV 4 in 1 Diagnostic Test
- Status
- COMPLETED
- Phase
- N/A
Clinical Validation of the Aptitude Medical Systems Metrix Respiratory Panel Test in At-Home/Non-Laboratory Settings
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Preparedness Through Respiratory Virus Epidemiology and Community Engagement
- Status
- RECRUITING
- Phase
- N/A
Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy
- Status
- RECRUITING
- Phase
- PHASE4
SURVEILLANCE, ASSESSMENT AND DETECTION OF INFLUENZA ASSOCIATED RESPIRATORY INFECTIONS IN HIV POSITIVE AND NEGATIVE INDIVIDUALS IN LUSAKA, ZAMBIA
- Status
- RECRUITING
- Phase
- N/A
Clinical Evaluation of the VitaSIRO Solo™ Respiratory Assay
- Status
- COMPLETED
- Phase
- N/A
Vaccine Effectiveness of a Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing RSV Hospitalizations in Adults
- Status
- RECRUITING
- Phase
- PHASE4
A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients
- Status
- RECRUITING
- Phase
- NA
Effectiveness And Impact Of Nirsevimab In Chile (NIRSE-CL)
- Status
- RECRUITING
- Phase
- N/A
Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)
- Status
- RECRUITING
- Phase
- N/A
Adherence to Palivizumab Prophylaxis
- Status
- COMPLETED
- Phase
- NA
A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Lot Consistency for RSVpreF in a Population of Healthy Adults 18 to ≤49 Years of Age
- Status
- COMPLETED
- Phase
- PHASE3
The Impact of a Short Intervention During RSV Prophylaxis on Influenza Vaccination Rate.
- Status
- UNKNOWN
- Phase
- NA